Table 4.

Scores of health survey (SF-36) at the baseline stage

	SF-36		P-value
	HS016 (n = 416)	Adalimumab (n = 232)
Physical function	− 1.38 ± 0.95	− 1.46 ± 1.00	0.353
Role physical	− 1.90 ± 0.82	− 2.01 ± 0.76	0.088
Bodily pain	− 1.61 ± 0.80	− 1.69 ± 0.79	0.188
General health	− 2.14 ± 0.93	− 2.15 ± 0.97	0.858
Vitality	− 1.01 ± 0.85	− 1.09 ± 0.84	0.239
Social function	− 1.59 ± 0.96	− 1.64 ± 0.94	0.480
Role emotional	− 1.58 ± 1.15	− 1.54 ± 1.18	0.715
Mental health	− 0.90 ± 0.98	− 0.91 ± 1.00	0.967
PCS	31.87 ± 7.55	30.78 ± 7.84	0.082
MCS	39.55 ± 9.67	39.74 ± 10.36	0.816

All data is presented as mean ± SD. MCS, mental health composite score; PCS, physical health composite score